Restructuring Skin Cancer Care in Ontario: A Provincial Plan.

Merkel cell carcinoma basal cell carcinoma keratinocyte carcinoma management plan melanoma organization of care pathway map skin cancer squamous cell carcinoma

Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
12 03 2021
Historique:
received: 29 12 2020
revised: 28 02 2021
accepted: 06 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 25 9 2021
Statut: epublish

Résumé

There is a global rise in skin cancer incidence, resulting in an increase in patient care needs and healthcare costs. To optimize health care planning, costs, and patient care, Ontario Health developed a provincial skin cancer plan to streamline the quality of care. We conducted a systematic review and a grey literature search to evaluate the definitions and management of skin cancer within other jurisdictions, as well as a provincial survey of skin cancer care practices, to identify care gaps. The systematic review did not identify any published comprehensive skin cancer management plans. The grey literature search revealed skin cancer plans in isolated regions of the United Kingdom (U.K.), National Institute for Health and Care Excellence (NICE) guidelines for skin cancer quality indicators and regional skin cancer biopsy clinics, and wait time guidelines in Australia and the U.K. With the input of the Ontario Cancer Advisory Committee (CAC), unique definitions for complex and non-complex skin cancers and the appropriate cancer services were created. A provincial survey of skin cancer care yielded 44 responses and demonstrated gaps in biopsy access. A skin cancer pathway map was created and a recommendation was made for regional skin cancer biopsy clinics. We have created unique definitions for complex and non-complex skin cancer and a skin cancer pathways map, which will allow for the implementation of both process and performance metrics to address identified gaps in care.

Identifiants

pubmed: 33809399
pii: curroncol28020114
doi: 10.3390/curroncol28020114
pmc: PMC8025818
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1183-1196

Références

Health Policy. 2012 Apr;105(1):65-70
pubmed: 22136810
J Cutan Med Surg. 2019 Nov/Dec;23(6):586-594
pubmed: 31462069
J R Soc Med. 2007 Jul;100(7):309-13
pubmed: 17606750
BMC Med. 2016 Feb 23;14:35
pubmed: 26904977
Curr Oncol. 2019 Feb;26(1):e94-e99
pubmed: 30853814
Health Policy. 2016 Dec;120(12):1378-1382
pubmed: 27823827
Med J Aust. 2007 Aug 20;187(4):215-20
pubmed: 17708723
J Thorac Oncol. 2013 Jul;8(7):876-82
pubmed: 23575416
Adv Exp Med Biol. 2014;810:120-40
pubmed: 25207363
J Surg Oncol. 2018 Mar;117(4):597-617
pubmed: 29228470
J Oncol Pract. 2012 May;8(3 Suppl):e38s-43s
pubmed: 22942833
Acta Oncol. 2017 Jul;56(7):943-948
pubmed: 28418710

Auteurs

John Milkovich (J)

Surgical Oncology Program, Ontario Health-Cancer Care Ontario, Toronto, ON M5G 2L7, Canada.

Tim Hanna (T)

Division of Cancer Care and Epidemiology, Cancer Research Institute at Queen's University, Kingston, ON K7L 3N6, Canada.
Department of Oncology, Queen's University, Kingston, ON K7L 5P9, Canada.

Carolyn Nessim (C)

Division of Dermatology and Medical Oncology, The University of Ottawa, Ottawa, ON K1H 8L6, Canada.

Teresa M Petrella (TM)

Sunnybrook Health Sciences Centre, Department of Medical Oncology, Toronto, ON M4N 3M5, Canada.

Louis Weatherhead (L)

Division of Dermatology and Medical Oncology, The University of Ottawa, Ottawa, ON K1H 8L6, Canada.

An-Wen Chan (AW)

Department of Medicine, Women's College Hospital, Toronto, ON M5S 1B2, Canada.

Jonathan C Irish (JC)

Surgical Oncology Program, Ontario Health-Cancer Care Ontario, Toronto, ON M5G 2L7, Canada.
Department of Medicine, University of Toronto, Toronto, ON M5S 1B2, Canada.

Christian Murray (C)

Department of Medicine, University of Toronto, Toronto, ON M5S 1B2, Canada.

Grace Bannerman (G)

Clinical Institutes and Quality Programs, Ontario Health, Toronto, ON M5G 2L7, Canada.

Claire Holloway (C)

Clinical Institutes and Quality Programs, Ontario Health, Toronto, ON M5G 2L7, Canada.

Katharina Forster (K)

Clinical Institutes and Quality Programs, Ontario Health, Toronto, ON M5G 2L7, Canada.

Laura Pazzano (L)

Clinical Institutes and Quality Programs, Ontario Health, Toronto, ON M5G 2L7, Canada.

Frances C Wright (FC)

Sunnybrook Health Sciences Centre, Department of Medical Oncology, Toronto, ON M4N 3M5, Canada.
Department of Medicine, University of Toronto, Toronto, ON M5S 1B2, Canada.
Clinical Institutes and Quality Programs, Ontario Health, Toronto, ON M5G 2L7, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH